SK bioscience Appoints New Executives to Accelerate New Growth Strategies
/PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe,...
Stay updated with breaking news from Harry Kleanthous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe,...
Global experts continue to join SK bioscience, while its U.S. corporate entity is being establishedCompany plans to strategically invest in person...
Washington: A new vaccine for COVID-19 that is entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. The vaccine, called NVD-HXP-S, is the first in clinical trials to use a new molecular design that is widely expected to create more potent antibodies than the current generation of vaccines. And the new vaccine could be far easier to make. Existing vaccines from companies like Pfizer and Johnson & Johnson must be produced in specialised factories using hard-to-acquire ingredients. In contrast, the new vaccine can be mass-produced in ch...